Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019

Home/Client News/Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019

Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019

FLORHAM PARK, N.J., Sept. 10, 2019 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced an oral presentation at the upcoming European Society for Medical Oncology (ESMO) Congress 2019 being held in Barcelona, Spain from September 27 – October 1, 2019.

By | 2019-09-10T16:16:35+00:00 September 10th, 2019|Client News|Comments Off on Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019